Pular para o conteúdo principal

INTEGRATED SUSTAINABILITY REPORT 2023

Natural capital

sdg:

  • SDG 3 : Good Health and Well-Being
  • SDG 12: Responsible Consumption and Production
  • SDG 13: Climate Action

sdg:

  • 3

  • 12

  • 13

  • 3

    SDG 3 : Good Health and Well-Being

  • 12

    SDG 12: Responsible Consumption and Production

  • 13

    SDG 13: Climate Action

Environmental management

GRI 2-25

Our concern for the environment is evident in the Company’s strategic drivers, in the Code of Conduct, as well as in our ESG Strategic Planning and comprises the organization’s and executives’ performance goals and targets. We have a Health, Safety, and Environment Policy that lays out guidelines on the topic and guides our actions.

We work to promote the rational use of natural resources and develop projects to reduce their consumption, thus mitigating our environmental impact. To monitor the consumption of natural resources, we rely on a tool (Schneider Electric’s Resource Advisor), which allows for real-time monitoring of water and electricity consumption in hospital units. The tool consolidates all environmental indicators onto a single platform, facilitating management and replacing internal KPI systems. In addition to the environmental data collection tool, we have an ESG management tool that incorporates key sustainability reporting methodologies.

83% do consumo de energia proveniente de fontes renováveis
Redução de 13% no total de resíduos perigosos gerados
Redução de 5% no total de resíduos gerados

133

units with

71

units

For the operation of our lighting systems, air conditioning, heating, water pumping, elevators, and medical equipment, we primarily use power supplied by utility companies. Generators are only activated when necessary, either due to power outages from the utility company or for equipment maintenance purposes.

We monitor monthly power consumption in all hospital units in real-time (Resource Advisor), assisting in conscious consumption and power savings.

This is a strategic material topic according to our ESG Strategic Planning.

Renewable energy

Energy consumption - renewable sources | GRI 302-1

20239

2022 8,9

20219

MWh⁵ GJ⁴ MWh⁵ GJ⁴ MWh⁵ GJ⁴

Comparison to previous report7

Electricity³ Conventional electricity (Captive Use / Utility Companies)³ 12,641.66 45,509.98 (63%) 18,672.55 67,221.17 (72%) 47,846.39 172,247.00 (89%)
Diesel (generators) 7,517.75 27,063.91 (37%) 7,183.97 25,862.29 (28%) 5,652.06 20,347.43 (11%)
Total electricity 20,159.41 72,573.89 (34%) 25,856.52 93,083.46 (42%) 53,498.45 192,594.43 (60%)
Heating Diesel 195.06 702.22 (0%) - - - -
Gasoline 1,447.11 5,209.61 (4%) - - - -
Liquefied Petroleum Gas (LPG) 5,420.90 19,515.22 (14%) 5,634.30 20,283.46 (16%) - -
Natural Gas 32,168.27 115,805.76 (82%) 30,200.77 108,722.77 (84%) 35,498.08 127,793.10 (100%)
Total Heating 39,231.34 141,232.81 (66%) 35,835.07 129,006.24 (58%) 35,498.08 127,793.10 (40%)

Cooling and steam production for consumption and self-generation using unused fuels1

N/A

Energy sale1

N/A
Total energy - non-renewable sources 59,390.75 213,806.70 61,691.58 222,089.70 88,996.54 320,387.53
Rate of non-renewable sources (GJ/pt./ day) GRI 302-3⁷ 0.076 0.083 0.078 Decreased

Renewable energy

Energy consumption - renewable sources | GRI 302-1 2023⁹

2022 8,9

2021⁹
MWh⁵ GJ⁴ MWh⁵ GJ⁴ MWh⁵ GJ⁴ Comparison to previous report²
Electricity³ Conventional electricity (Captive Use / Utility Companies)³ 50,566.64 182,039.90 (16%) 248,588.90 380,919.95 (39%) 143,539.17 516,741.00
Incentivized electricity (Wholesale Energy Market) 255,667.91 920,404.48 (84%) 167,973.89 604,706.00 81,249.44 292,498.00
Total electricity 306,234.55 1,102,444.38 (100%) 416,562.79 985,625.95 224,788.61 809,239.00
Ethanol 14.83 53.37 (100%) N/A N/A N/A N/A
Total heating 14.83 53.37 N/A N/A N/A N/A
Cooling and steam production for consumption and self-generation using unused fuels¹ N/A
Energy sale¹ N/A
Total energy - renewable sources 306,249.38 1,102,497.75 416,562.79 985,625.95 224,788.61 809,239.00

Rate of renewable sources (GJ/pt./day) GRI 302-3 2

0.060 0.142 0.216 Decreased

Consolidated

Energy consumption within the organization | GRI 302-1 2023 2022 2021
MWh⁵ GJ MWh⁵ GJ MWh⁵ GJ
Non-renewable sources 59,390.75 213,806.70 (16%) 61,691.58 222,089.70 (18%) 88,996.54 320,387.53 (28%)
Renewable sources 306,249.38 1,102,497.75 (84%) 416,562.79 985,625.95 (82%) 224,788.61 809,239.00 (72%)
Total 365,640.13 1,316,304.45 478,254.37 1,207,715.65 313,785.15 1,129,626.53
GJ/pt./day GRI 302-3 0.136 0.224 0.294

1 Not applicable (N/A). The Rede D’Or does not consume fuels for cooling processes, steam generation, and does not sell energy.

2 There was a gradual reduction in the consolidated energy intensity of hospital units when compared to previous years (approximately -39% between 2023 vs. 2022), even though absolute consumption increased, which reinforces the company’s energy efficiency actions with its goal of reducing energy consumption (see “Energy Efficiency” and “ESG Goals”) [GRI 302-4]. Considering that hospitals account for almost 95% of the company’s total consumption, it should be noted that electricity consumption in the captive market has been reducing every year as units join the Free Energy Market (FEM), which in turn means that renewable electricity consumption increases with each reporting cycle. Adherence to the FEM is a company strategy in which this action is driven by a specific goal (see the topic “ESG Goals”). With this, in line with the company’s environmental commitment, we can see that our energy consumption matrix within the organization is around 80% from renewable energy and 20% from non-renewable energy, noting that the composition of renewable energy in relation to non-renewable energy has been favored every year.

3 Captive electricity consumption (renewable and non-renewable) is estimated based on total consumption and consumption in the free energy market, in which “total electricity consumption (captive) = total electricity consumption - total electricity consumption in the free energy market”. In 2022, we reported electricity without distinguishing between renewable and non-renewable sources, and we had reported 1,052,847.12 GJ for 2022 and 981,486 GJ for 2021, as we did not have a reference for this segregation of conventional market electricity. In this reporting cycle, we adopted as a reference the Interactive National Energy Balance (BEN in Portuguese), which segregates the “Electric Flow of Internal Energy Supply” into renewable, non-renewable, and imported electricity (on the website, select “1. Energy Analysis and Aggregated Data” and “1.14. Electric Flow”). Thus, we adopted the premise of estimating our sources of electricity consumption from these theoretical data for renewable and non-renewable energy. Regarding “imported electricity,” we consider it as non-renewable, as a precaution, since the source is not traceable, it is reasonable to assume that a significant portion thereof comes from the surplus sale of Itaipu from Paraguay to Brazil (hydroelectric - renewable) [GRI 2-4]. Electricity consumption from the Free Energy Market includes hospitals and other business units, such as medical centers (CEMEDs), which can be located inside the hospital units. However, consumption in CEMEDs accounts for approximately 2% of the total, so it is insignificant in the total amount;

4 Until the publication of this report, the electric flow for 2023 had not been published. Therefore, we adopted as a reference the average electricity flow from 2020 to 2022, which will be restated in the next report after the publication of the 2023 electric flow. Thus, we considered a consumption of 80% renewable electricity and 20% non-renewable (which includes imported energy), estimating 182,039.90 GJ from renewable sources (163,972.56 GJ from hospitals) and 45,509.98 GJ from non-renewable sources (40,993.14 GJ from hospitals). In 2022, we recorded a consumption of 85% renewable energy, 12% non-renewable and 3% imports (15% total non-renewable), respectively, so we estimate a total of 380,919.95 GJ from renewable sources (376,165.73 GJ from hospitals) and 67,221.17 GJ from non-renewable sources (66,382.19 GJ from hospitals). In 2021, we recorded a consumption of 75% renewable energy, 22% non-renewable and 3% imports (25% total non-renewable), so we estimate a total of 516,741.00 GJ from renewable sources (512,489.48 GJ from hospitals) and 172,247.00 GJ from non-renewable sources (170,829.83 GJ from hospitals).

5 Energy conversion between GJ and MWh is 1 kWh = 0.001 MWh and 1 kWh = 0.0036 GJ.

6 The energy intensity within the organization has been restated from 0.82 GJ/pt.day to 0.294 GJ/pt.day for 2021; for 2022, from 0.87 GJ/pt.day to 0.224 GJ/pt.day, as duplicates were identified in the previous denominator rationale, and now considers only hospital units, as “pt.day” is a specific indicator for this type of business. [GRI 2-4].

7 As it is a metric with a denominator specific to owned hospital units, the energy intensity rate calculation considers only this business typology. In any case, the amount of energy for hospitals corresponds to practically 100% of the total value. Thus, the total estimated energy consumption within the organization in hospitals was considered as numerator at 170,829.83 GJ (non-renewable) and 512,489.48 GJ (renewable), totaling 683,319.31 GJ for 2021; and 66,382.19 GJ (non-renewable) and 376,165.73 GJ (renewable), totaling 442,547.92 GJ for 2022; and 40,993.14 GJ (non-renewable) and 163,972.56 GJ (renewable), totaling 204,965.69 GJ for 2023. We must point out that consumption in hospital units represents, on average, 95% of the total consumption reported in GRI 302-1, which is why we have chosen to report it in this way. We recognize that separate, consolidated reporting is ideal, and we will evaluate this possibility for future reporting cycles

8 The values presented in 2022 for Maternidade Star were only considered from May onwards, when the unit began its operations.

9 For M&A, consumption begins in the month of acquisition.

Energy consumption outside the organization

Consumption of non-renewable upstream fuel for transportation (GJ)1

2023 2022 2021
GJ GJ GJ
Diesel 413.97 (9.7%) 41.37 (6.7%) N/A
Gasoline 2,343.51 (54.9%) 572.68 (93%) N/A
Compressed Natural Gas (CNG) 1,511.35 (35.4%) N/A N/A
Total 4,268.83 614.05 N/A
Intensity (GJ/pt./day)⁴ 0.00025 0.00014 N/A

1 There was no energy consumption outside the organization in downstream categories.

2 The consumption of non-renewable upstream transportation fuels increased compared to the previous year. This increase is attributed to the greater accuracy of the data obtained from third-party companies regarding this indicator.

3 Data for 2021 was not reported; the Company started reporting in 2022. Data restated from 0.19 GJ/pt.day to 0.00014 GJ/pt.day, as duplicates were identified in the denominator rationale, and now considers only hospital units, as “pt.day” is a specific indicator for this type of business. [GRI 2-4]

4 As it is a metric with a denominator specific to owned hospital units, the energy intensity rate calculation considers only this business typology. In any case, the amount of energy used by hospitals corresponds to practically 100% of the total value. Thus, total energy consumption outside the organization in hospitals was considered as the numerator, at 369.89 GJ for 2022; and 1,046.67 GJ for 2023.

Consumption of non-renewable upstream fuel for transportation (GJ)1

2023 2022
GJ GJ
Ethanol 1,507.36 (110%) 1.79 (100%)

1 Energy intensity does not apply to this indicator since consumption was not from a hospital unit.

Energy intensity ratio

Measurement unit 2023 2022 2021
GJ/pt./day

GJ/pt./day1

GJ/pt./day1

Energy intensity ratio within the organization1,2

0.136 (approx.100%) 0.224 (approx.100%) 0.294 (100%)

Energy intensity ratio outside the organization1,2

0.00025 (approx.0%) 0.00014 (approx.0%) N/A
Consolidated energy intensity ratio² 0.136 0.224 0.294

1 Energy intensity within the organization was rectified from 0.82 GJ/pac.day to 0.294 GJ/pac.day for 2021; for 2022, from 0.87 GJ/pac.day to 0.224 GJ/pac.day. The intensity outside the organization was rectified in 2022, from 0.19 GJ/pac.day to 0.00014 GJ/pac.day. For both cases, duplicity was identified in the rationale of the denominator [GRI 2-4]. It is possible to note that, until then, the energy outside the organization is not representative in comparison to that within the organization;

2 As it is a metric whose denominator is specific to its own hospital units, the intensity calculation only considers this type of business. In any case, the amount of energy used by hospitals corresponds to practically 100% of the total value. See more details in explanatory note 2 of GRI 302-1 and explanatory note 4 of GRI 302-2.

In 2023, we achieved the milestone of 90% of our energy consumption coming from renewable sources through the Free Energy Market (MLE, in Portuguese). This goal is part of the Rede D’Or’s ESG Strategic Planning, which will guide our actions until 2030. The initiative to migrate electricity consumption from the captive market to the free market began in 2019 with the São Lucas (SE) and UDI (MA) hospitals, and continued in 2020 and 2021 with the Perinatal Barra and Laranjeiras (RJ), Santa Cruz (PR), Aliança (BA), São Carlos (CE), Balbino (RJ), Biocor (MG), Nossa Senhora das Neves (PB), and Novo Atibaia (SP) hospitals.

In 2023, we continued the migration plan for another 27 consuming units, totaling 13 MW average of contracted incentivized energy (wind, solar, biomass, and small hydroelectric plants). We currently have 71 consuming units in the Free Energy Market (located in 66 hospitals and medical centers), equivalent to 35 MWaverage, and we aim to reach 74 units by 2025.

The units consuming incentivized energy will be recognized with the International Renewable Energy Certificate (I-RECs), internationally applied to track environmental attributes and prove that the electricity consumed by the company comes from 100% clean sources.

Data on energy consumption from the Free Energy Market can be found in “GRI 302-1 - renewable energy consumption”. We have an MLE-related target in the “Energy” material topic, which can be seen in the “ESG Goals” chapter.

We promote conscious and efficient energy consumption through the Energy Efficiency Program, which includes actions in electricity, water, and combustible gas. Among the noteworthy projects within the program is the Energy Efficiency Project in Chilled Water Plants (CAGs in Portuguese), whose main focus is to ensure the efficiency of this system by optimizing infrastructure, operation, and monitoring, also relying on artificial intelligence algorithms and machine learning to achieve the best equipment performance and reduce energy consumption.

We currently have 23 Energy Efficiency projects in operation in CAGs, with 20 ongoing contracts, five under deployment and three in the contracting stage,—in addition to another 32 identified as potential projects to be applied. Each of these projects undergoes a rigorous economic, financial, and technical feasibility analysis by the Company’s corporate engineering and maintenance team before being effectively implemented.

In 2023, the 15 projects in operation in the CAGs recorded a reduction in electricity consumption of 16.9% (5,257.40 MWh) compared to the same period in the previous year. This result can be seen in the target for the “Energy” material topic in the “ESG Goals” topic. This reduction is equivalent to 394.3 tons of CO2 avoided and represents net savings of BRL 1,625,172.07 [GRI 3-3, 302-4].

Hospital São Luiz Itaim (SP), for example, implemented a robust energy efficiency program in 2023. An expert, supported by a remote team of engineers and a complex automation system, runs a program aimed at improving the performance and energy efficiency of the chillers. Fine adjustments are constantly made to all equipment parameters considering conditions, allowing them to operate with greater efficiency and lower energy consumption. This, coupled with efficient facades, reduces monthly energy costs, maintains the hydrotechnical comfort of the building, provides safety for patients, ensures adequate lighting during clinical and surgical procedures, and for general use of the building by patients and technical staff.

Reduction in energy consumption

16.9%

in CAGS in 2023

Net savings

BRL 1.6

MILLION

The optimization of the heat recovery system aims to reduce natural gas consumption by utilizing the heat rejected by the chiller, which is usually directed outside the building, to preheat water stored in thermal storage tanks for later use by the unit. This system is operational at the São Caetano unit in São Paulo, with the possibility of activation in other Rede D’Or units that have the system, which are under analysis.

For other units that do not have the heat recovery function, the use of the heat pump is under consideration, a technology that can meet a significant portion of the fuel gas consumption of the units and is currently undergoing pilot testing and further studies at the Criança unit in São Paulo.

The Company’s water and effluent management is governed by two internal regulations available to all Rede D’Or’s business units, referencing various federal and state legal regulations, such as the Ministry of Health’s Ordinance 888/2021 and National Environmental Council (Conama, in Portuguese) Resolution 430/2011, ensuring that management of said resources comply with the standards set by proper authorities [GRI 303-2].

Crucial to our operations, water used in our healthcare units is withdrawn through three possible means: from a utility company, wells, and/or water trucks. Regular quality analyses are conducted for all three sources by an independent laboratory to assess their physicochemical and microbiological potability parameters—color, turbidity, conductivity, pH, total dissolved solids, ammonia, alkalinity, hardness, total coliforms, Escherichia coli, etc [GRI 303-4]. Sampling defines the analysis collection points, conducted by the Maintenance department and the Hospital Infection Control Committee of the unit, so that each point can strategically represent the entire area, with special attention to areas designated as critical. This ensures the quality of the water supplied to our units [GRI 3-3, 303-2].

Within hospital activities, we have two potential local impact agents on water bodies: clinical analysis laboratories and pathological anatomy laboratories. This is due to the use of chemical reagents and other substances commonly used to increase contrast and optimize bacterial analysis, such as dyes, if they come into contact with water bodies. To prevent these potential impacts, thus preserving the local ecosystem and the occupational safety of employees, all inputs used in these activities have safety data sheets (SDS) containing instructions on the correct disposal of these materials. The equipment used in these places is connected to properly sealed and identified containers, ensuring no leakage into the sewage system, and later sent for treatment and final disposal by companies complying with all environmental and legal requirements [GRI 3-3].

After use, water undergoes treatment at Sewage Treatment Plants, in the case of units located where the water and sewage utility company does not have effluent collection systems, in order to meet all parameters outlined in National Environment Council’s (Conama, in Portuguese) Resolution 430/2011, based on the classification of the water body into which the effluent will be subsequently discharged, in addition to local laws [GRI 303-2].

We conduct regular environmental audits at all hospital units to map and identify environmental aspects and potential impacts, establishing action plans for deviations and non-compliances. External audits are conducted on critical service suppliers, such as suppliers involved in waste management through collection, transportation, treatment, and/or final disposal, as well as laundries. Audits on these suppliers are conducted in two stages, involving the collection of relevant documentation for potential legal compliance assessment and on-site visits to inspect the structure and operational procedures [GRI 2-25, 3-3].

We do not have a specific methodology for evaluating water abstraction in water-stressed areas, as the Company is studying the possibility of starting research on the subject [GRI 303-3].

Water withdrawal, consumption, and discharge

Water withdrawal, consumption and discharge by source¹ 2023 2022

20215,6

ML ML ML Comparison to previous report⁷

Water withdrawal GRI 303-3 2,3,4

Third-party water (freshwater) Concessionary 1,930,989.46 (60%) 1,930.99 1,750,698 (77%) 1,750.70 1,676,447 (73%) 1,676.45
Water tanker 989,489 (31%) 989.49 314,089 (14%) 314.09 209,838 (9%) 209.84
Groundwater (freshwater) Artesian well 308,660 (9%) 308.66 214,316 (9%) 214.32 409,956 (18%) 409.96
Total water withdrawal 3,229,138 3,229.14 2,279,102 2,279.10 2,296,240 2,296.24
Total water discharge GRI 303-4² Third-party water (freshwater) Utility Company 1,544.791 1,544.79 1,400,558 1,400.56 1,341,157 1,341.16
Water tanker 791,591 791.59 251,271 251.27 167,870 167.87
Groundwater (freshwater) Artesian well 246,928 246.93 171,453 171.45 327,964 327.96
Total water discharge 2,583,310.21 2,583.31 1,823,282 1,823.28 1,836,992 1,836.99
Total water consumption GRI 303-5 ³ 645,828 645.83 455,820 455.82 459,248 459.25
Consumption rate (m3/pt./day)⁸ 0.237 0.165 0.192 Increased

1 Report adjusted according to GRI 303-3, 303-4, and 303-5 standards, while keeping previously reported data unchanged. For benchmarking purposes, peer comparison, and performance evaluation, we also report rate per patient/day (GRI 2-4). It is not yet possible to measure water withdrawal and discharge in water-stressed areas, if any. It is also not possible to differentiate between categories of freshwater (total dissolved solids  1,000 mg/L) and/or other types of water (total dissolved solids > 1,000 mg/L).

2 Since it is not possible to accurately measure water discharge, we adopt the technical estimation reference, the “return coefficient (c)” defined by ABNT NBR 9649:1986, which sets out “C = 0.8”, where C represents the “average ratio between volumes of sewage produced and water actually consumed.” Therefore, we consider that 80% of withdrawn water has been converted into disposed sewage. In other words, “water discharge = 0.8 x water withdrawal;”

3 It is not possible to measure water consumption, so we follow the rationale provided by GRI 303-5, where “water consumption = total water withdrawal – total water discharge.” This is the first time we report in this manner (GRI 2-4).

4 For reporting to ANAHP, we define water consumption as water withdrawal to align our reporting with the indicators of this organization, which are the data published in the “Observatório Anual”(Annual Observatory).

5 2021 data does not include information on Hospital Guaianases from January to June.

6 The 2021 data for Hospital São Lucas RJ only includes the month of August.

7 Regarding performance, there was an increase in water collection due to an expansion in the number of beds and units, which led to an increase in consumption intensity when compared to the previous year. This year, for these indicators, the hospital units (with the exception of the Badim, Cinco de Outubro and Yutaka Takeda units), oncology units, Richet units, two IDOR units and three corporate units are being considered.

8 Since it is a metric whose denominator is specific to own hospital units, the intensity calculation only considers this type of business. In any case, the amount of water collected by hospitals corresponds, on average, to 98% of the volume. Therefore, the total water consumption in hospitals was considered as the numerator at 454,145.18m³ for 2021; 439,686.52m³ for 2022; and 642,852.10m³ for 2023.

9 There was no change in water storage in 2023.

Water is a strategic material topic according to our ESG Strategic Plan. The Water Efficiency Project seeks to reduce costs related to water supply and consumption, through operations optimization and remote monitoring. Using newer, more efficient equipment brings the benefit of these savings, alongside periodic tests of cisterns, pipelines, leak detection, and even adjustments to existing equipment and process guidance (where possible), all of which has a substantial impact on consumption. Launched in 2021 at four hospital units, the program was already implemented in 15 units by the end of 2023, with new participating units expected for the next reporting cycle.

The program also features the TDRR remote monitoring system, with artificial intelligence and identification of each unit’s profile, enabling real-time monitoring of water consumption by analyzing building behavior and anticipating potential consumption increases, thus optimizing project performance. The methodology evaluates reservoir consumption levels, consumption by time (nightly, daily, monthly), ongoing leak detection, operational safety, monitors pump activations and failure, consumption reduction, and offers an alarm system via app, text message, email, and WhatsApp.

Units complement the program with their own initiatives, including the installation of delay tank systems, rainwater harvesting for reuse, installing automatic faucets, and reusing water from air conditioning units.

Additionally, we encourage the reduction of water consumption in our employees’ and associates’ homes through campaigns on responsible usage in our units. On World Water Day, for example, Hospital São Luiz São Caetano provided informative posters with important tips for reducing water consumption in households.

In 2023, we added nine units, bringing the total number of participating units in the project to 15. As a result, a 17% reduction in water consumption was recorded in 2023, equivalent to 111,334.84 m³. This translated to net savings of BRL3,910,935.73. This percentage is part of the target monitored under the “Water and Effluent” material topic, as presented in the “ESG Goals” chapter. We anticipate the inclusion of at least 6 more units in the next reporting cycle.

Although consumption rates increased [GRI 303] between 2023 and 2022, the effect of the Water Efficiency Project is key to preventing an even marked increase.

Redution in

water consumption in the units participating in the project

net savings

million

Climate change caused by increased Greenhouse Gas (GHG) emissions represents one of the greatest global challenges we face today. It impacts the environment, food security, human health, the economy, and social justice. Mitigating GHG emissions and adopting adaptive measures are crucial to reducing the impacts of climate change and promoting a sustainable, resilient future.

Our Policy on Climate Change, which was approved by the Board of Directors, lays down the Company’s main guidelines and commitments to manage climate change risks and its impact on our units and businesses, providing impact identification, mitigation, and adaptation mechanisms. We also seek to raise awareness among our employees and suppliers about the importance of the matter, while serving as catalysts for the transition towards a low-carbon economy.

Climate change matters are addressed by the Executive Board and committees, with ongoing analysis of related indicators.

We are engaged in many international initiatives aimed at mitigating climate change. We are signatories to the UN Global Compact, members of the GHG Protocol, and the Global Green and Healthy Hospitals Network, in which we actively participate in the Climate Working Group. Every year we respond the Corporate Sustainability Index (ISE B3) questionnaire and the Carbon Disclosure Project (CDP) – Climate Change (ENG), in which we achieved a B score in both 2022 and 2023. We are also part of B3’s Carbon Efficient Index (ICO2) portfolio.

We have also pledged our commitment to cut CO2 emission intensity by 2030 through the Race to Zero initiative. To reduce direct emissions, for example, we initiated efforts with anesthesiologists in 2023 to establish protocols for the rational use of nitrous oxide (N2O).

To educate and engage our employees on this issue, we have a specific module in our Sustainability Learning Trail addressing climate change impacts from a healthcare perspective. Additionally, we promote campaigns such as the online event on National Climate Change Awareness Day, themed ‘climate crisis at the forefront of gender, health, and social justice debate.’

In our efforts to tackle climate change, we have been quantifying our impacts since 2016 through an annual, continuous, and enhanced reporting of our greenhouse gas (GHG) emissions inventory. Since 2020, the data obtained have undergone external audits and are publicly disclosed in the Public Emissions Registry.

For publishing our report according to international standards, we were awarded the Gold Seal by the Brazilian GHG Protocol Program (PBGHGP in Portuguese) for our inventories of the 2021 and 2022 cycles.

The seal certifies our corporate inventory for achieving the highest level of qualification in reporting, following concepts and guidelines established by the PBGHGP and complying with ISO 14064-3:2007. The inventory includes all gases internationally recognized as GHGs (regulated by the Kyoto Protocol) and adheres to both national and international methodologies.

Climate Change is a strategic material topic according to our ESG Strategic Planning. Given that the TCFD, one of the most significant frameworks for climate transparency, has been discontinued by the entity itself following the publication of the ISSB IFRS S2 standard (“Climate-Related Disclosure”), we are internally focused on structuring our climate management information in accordance with this standard. currently, our reporting remains within the TCFD framework (refer to Annex).

Climate management is overseen by the Risk and Internal Controls Executive Office with support from the Sustainability and Environment Department, which regularly submit reports to the Sustainability Committee, responsible for forwarding results to the Board of Directors—the highest body responsible for approving climate-related policies, projects, and commitments. Climate-related goals and results are not yet factored into the calculation of variable compensation for employees and executives.

We conducted a comprehensive study of risks and opportunities based on physical climate scenarios (available in Portuguese/English) from the Intergovernmental Panel on Climate Change (IPCC) and transition scenarios from the International Energy Agency (IEA) . The assessment of risks and opportunities related to climate scenarios was divided into physical scenarios (RCP 2.6, and RCP 2.8) and transition scenarios (NZE 2050, and STEPS). This marks an initial step in developing our climate risk matrix, enabling the Company to anticipate responses to risk costs and investment opportunities and, consequently, assess the criticality level identified within the risk matrix.

We use scenario analysis, climate risk matrices, risk management policies, climate change policies, and greenhouse gas emissions inventories as the basis for our climate strategy.

1 Details on governance; strategy; risk and opportunity management and climate metrics have been reported in the TCFD Annex.

2 [SASB HC-DY-450a.1] We have mapped physical climate risks associated with health impacts. We have identified climate-related risks/opportunities. As a result, risk factors for vector-born and zoonotic diseases have been mapped nationwide (e.g., malaria, dengue and others), as well as those related to respiratory, cardiovascular and kidney diseases. These risks can have an impact on indicators that can influence our business prospects, such as morbidity and mortality rates. These risks were assessed as potential, so no quantitative assessment has yet been carried out to determine if these risks and opportunities are already impacting our business. Regarding preparation for and response to emergencies associated with climate risks, we already have operational actions in place to address climate emergencies, including, but not limited to, insurance, JCI international accreditations and emergency and evacuation plans, with drills, among others. The breakdown was reported in the “Strategy” chapter, item (a) of the TCFD Report ‘Chart 1’.

Climate risk assessment is integrated into the risk assessment procedures of both the Company and its subsidiaries, as described in our Climate Risk Matrix. Climate risk management modeling is a specific process for managing climate change risks, i.e., a documented process that considers climate change risks and opportunities separately from other business risks and opportunities. However, as it is already considered a corporate risk and a sustainability material topic, it results from the unfolding of an already structured process integrated into our multidisciplinary risk management processes throughout the Company, where climate change risks and opportunities are integrated into our centralized corporate risk management program.

For physical scenarios, we assessed risks and opportunities taking into account climate factors like temperature increase, heatwaves, rainfall, and sea level rise under variables of economic, infrastructure, and health impact [SASB HC-DY-450a.1]. In transition scenarios, factors like power demand, fossil fuel consumption, and nitrous oxide use in anesthesia were taken into account under the variables of economic, image, and political/legal impact.

As a result of the assessment in physical scenarios, the infrastructure impact variable associated with environmental factors such as rainfall and sea level rise obtained the most significant estimated financial impact, considering structural damages from floods. Physical risk management of structural damages resulting from floods considers the cost involved in insurance maintenance [SASB HC-DY-450a.1].

As a result of the assessment in transition scenarios, we identified nitrous oxide usage as a high financial impact risk in the transition scenario (NZE 2050 and STEPS), with legislation being one of its impact variables. An energy-related opportunity was identified in both physical scenarios (RCP 2.5 and RCP 8.5) and transition scenarios (NZE 2050 and STEPS), underscoring its significance for the Company. To manage this transition risk regarding the use of nitrous oxide, we are currently rationalizing individualized reduction goals that we will continuously monitor. To take immediate action in the short term to reduce the consumption of this input, we have identified with the Anesthesiologists Chamber only the control of its consumption to almost negligible levels, with the opportunity being the potential of nearly zero consumption of this chemical for surgeries. To execute such an initiative, we must act to change the behavior of clients (physicians), an action that should not involve any costs.

We have identified two energy-related opportunities: savings through energy efficiency projects and savings on the electricity bill by migrating to the free energy market. These measures incurred in costs related to the maintenance of efficiency projects, whereas for the Free Energy Market, we perceive costs as operational costs inherent in contracts between the consuming entity and the supplier. Both opportunities can be found in the "Energy” Chapter.

The estimated financial implications of risks and opportunities were outlined in the CDP 2023 - Climate Change.

Details regarding risk management, including identification, assessment, prioritization, and management were reported in the TCFD Annex ("Risk Management” section, items a, b, and c). Additional information on climate risk and opportunity management and its integration with corporate risk management is available on our official website and through our Investor Relations channel.

1Details on governance; strategy; risk and opportunity management and climate metrics have been reported in the TCFD Annex.

2 [SASB HC-DY-450a.1] We have mapped physical climate risks associated with health impacts. We have identified climate-related risks/opportunities. As a result, risk factors for vector-born and zoonotic diseases have been mapped nationwide (e.g., malaria, dengue and others), as well as those related to respiratory, cardiovascular and kidney diseases. These risks can have an impact on indicators that can influence our business prospects, such as morbidity and mortality rates. These risks were assessed as potential, so no quantitative assessment has yet been carried out to determine if these risks and opportunities are already impacting our business. Regarding preparation for and response to emergencies associated with climate risks, we already have operational actions in place to address climate emergencies, including, but not limited to, insurance, JCI international accreditations and emergency and evacuation plans, with drills, among others. The breakdown was reported in the “Strategy” chapter, item (a) of the TCFD Report ‘Chart 1’.

Climate management relies solely on metrics. These are segregated into cross-sectoral goals, which include common metrics and indicators monitored by all sectors of the economy (in particular those used for GHG emissions reporting); and sector-specific metrics, which are specific to our business typology (for example, the pt. day metric).

a Details on governance; strategy; risk and opportunity management and climate metrics have been reported in the TCFD Annex.

For publishing our report according to international standards, we were awarded the Gold Seal by the Brazilian GHG Protocol Program for our 2021 and 2022 inventories. The seal certifies our corporate inventory for achieving the highest level of qualification in reporting, following concepts and guidelines established by the PBGHGP and complying with ISO 14064-3:2007. The inventory includes all gases internationally recognized as GHGs (regulated by the Kyoto Protocol) and adheres to both national and international methodologies.

After preparing emissions inventory for hospitals, laboratories, some oncology clinics, and corporate offices, which have been externally assured, our current challenges are internal carbon pricing and monitoring scope 3 emissions, which involve the supply chain.

The Board of Directors and the Executive Board use emissions inventory data as a control and oversight tool and as a reference to assess emission activities and determine what reduction initiatives are effective. Additionally, they are used for reviewing, approving, and setting goals.

GHG Emissions1,2,3

2023 2022 2021 2020
Scope 1 (tCO2e)  67,385 (62%) 64,785 (58%) 108,388 (62%) 70,123 (69%) Comparison to previous report⁸

Intensity ratio (Scope 1/pt.day)5

0.025 0.024 0.046 0.040 Increased

Scope 2 (tCO2e) 4

Location - 12,450 (10%) Purchase option - 9,252 (9%) 12,537 (11%) 35,612 (20%) 16,253 (16%) Comparison to previous report⁸

Intensity ratio (Escopo 2/pac.dia) 5

Location - 0.004 Purchase option - 0.003 0.005 0.015 0.009 Decreased

Scope 3 (tCO2e)6

31,259 (26%) 33,448 (30%) 30,272 (17%) 15,389 (15%) Comparison to previous report8

Intensity ratio (Scope 3/pt.day)5

0.012 0.013 0.013 0.009 Decreased
Total emissions (tCO e) 107,8964 110,770 174,272 101,765 Comparison to previous report⁸

Total carbon intensity ratio (tCO2e/pt.day) 5

0.040 0.042 0.073 0.057 Decreased

1We use the tool from the Brazilian GHG Protocol Program, by Fundação Getulio Vargas (FGV), which is responsible for adapting the GHG Protocol method to the Brazilian context and developing calculation tools for estimating greenhouse gas (GHG) emissions. The provided calculation tools take identified emission sources as inputs, by Scope and category according to established metrics, along with conversion and emission factors. It is worth noting that we also use a conversion tool provided by the Sustainable Hospitals Project (PHS, in Portuguese), in partnership with the Climate Challenge, for the proper calculation of “incinerated waste”.

2 Data reported for 2023 includes 133 units in total: Hospitals 67, oncology clinics 26, clinical analysis laboratories 12, corporate office (05), and SulAmérica units, both corporate (18) and health (05) units. Data reported for 2022 includes 103 units in total: Hospitals (67) (Except Badim and Santa Isabel), oncology clinics (23), clinical analysis laboratories (12), and corporate office (1). Data reported for 2021 includes a total of 78 units, including hospitals, oncology clinics and laboratories.

3 The obtained data may include the following gases: CO2, CH4, N2O, HFCs (refer to GRI 305-7), but do not consider emissions of gases not regulated by the Kyoto Protocol as they are insignificant in the result.

4 Up to 2022, Scope 2 emissions were reported based on location. For 2023, reporting included location and purchase option.

5 GRI 305-4: Intensity ratio calculation only includes hospital units as it is a sector-specific metric for the business model. Calculations included 48 hospitals in 2020; 61 hospitals in 2021; 67 hospitals in 2022 (excluding Badim and Santa Isabel units); and 67 hospitals in 2023.

6For Scope 3, upstream categories were reported as “4. Upstream transportation and distribution,” “5. Waste generated in operations” and “6. Business trips.” Category 4 accounted for 148.05 tCO2e in 2021, 196.72 in 2022, and 341.55 in 2023; Category 5 accounted for 30,123.58 tCO2e in 2021, 32,175.21 in 2022, and 28,607.02 in 2023. Meanwhile, category 6 accounted for 1,075.98 tCO2e in 2022 and 2,310.56 in 2023. This last category started to be accounted for as of 2022.

7 To ensure transparency regarding our mitigation goal performance, we continue to report the 2020 data. However, for the emissions calculations of the 2020 reference year, we employed GWP AR4, and the goals were set based on this metric. We have updated our reporting to AR5 for all reference year emissions, thus there was a restatement of information in Scope 1 data, changing from 77,011 tCO2e to 70,123 tCO2e, and in Scope 3 data from 13,883 tCO2e to 15,380 tCO2e. As a result, total absolute emissions have been restated from 107,146 tCO2e to 101,756 tCO2e (GRI 2-4). The progress assessment of these goals can be found in the “ESG Goals” chapter. However, the figures in the Public Emissions Registry for 2020 are 61,259.86 tCO2e for scope 1; 12,337.28 tCO2e for scope 2; 9,415.40 tCO2e for scope 3.

8There was an increase in total scope 1 emissions, which is due to the higher number of inventoried units and the units’ maturity in terms of reporting this information in our indicator control. Total scope 2 and 3 emissions did not increase.

9 Total scope 1 biogenic emissions: 268.46 tCO2e

10 Total scope 3 biogenic emissions: 2,775.124 tCO2e

Scope 1:

In 2023, Rede D’Or expanded its coverage of inventoried units to 133 units, including hospitals, oncology clinics, laboratories and corporate offices. This substantial increase in the number of units compared to 2022, combined with the maturation of the units regarding control of environmental indicators, led to an upturn in scope 1 CO2 emissions.

Even though in 2023 there was a significant reduction in emissions linked to the use of nitrous oxide (Scope 1 - Fugitive Emissions category - N2O), which has a high global warming potential (GWP), its substitutes (since both are used for anesthesia) were widely used. It is important to note that, as stated above, we have signed a commitment to develop procedures and strategies to mitigate these offenders.

Finally, despite the increase in emissions linked to this scope, there was a reduction of approximately 2% in their amount compared to the previous year.


Scope 2:

For the second consecutive year, despite an increase in the number of quantified units, Scope 2 emissions declined due to two important factors: our ongoing commitment to the energy efficiency program in Chilled Water Plants (CAGs in Portuguese) and a reduction in the average electricity emission factor in 2023 according to the calculation methodology used by the Brazilian GHG Protocol Program.

In 2022, the annual average emission factor of the National Interconnected System (SIN in Portuguese) was 0.0426 tCO2/ MWh, and dropped to 0.0385 tCO2/MWh in 2023.


Scope 3:

Scope 3 emissions declined compared to the previous year, driven by a reduction in the generation of chemical waste (group B) and infectious waste (groups A and E). Although the majority of group A and E waste is autoclaved, in some regions of the country, incineration is the only treatment technology available for this type of waste. On the other hand, group B waste must be incinerated. Thus, given the decline in the generation of these types of waste, there was a subsequent reduction in emissions of this scope.

In addition, there was an update to the tool developed by the Brazilian GHG Protocol Program (Fundação Getulio Vargas - FGV), with the introduction a new spreadsheet for reference year 2023 that lists incineration as a possible waste treatment, which was not the case in the previous version, as well as new emission factors. In previous years, our emissions from waste incineration were calculated using a spreadsheet developed and published by the Healthy Hospitals Project (PHS in Portuguese).

GHG Emissions Scope 1, 2, 3

(tCO2e)

Substances considered in this indicator include Halon, Carbon Tetrachloride (CTC), Hydrochlorofluorocarbon (HCFC), Chlorofluorocarbon (CFC), and Methyl Bromide, which are substances regulated by the Montreal Protocol. The use of HCFC-22 (R22) gas, a refrigerant employed in air conditioning units, has been mapped.

According to the FGV’s GHG Protocol calculation tool version, one metric ton of CFC-11 is equivalent to approximately 4,660.00 metric tons of CO2 equivalent. Since the GHG Protocol tool allows us to calculate in metric tons of CO2 equivalent, and for HCFC-22 we had a total of 5,782.2 tCO2e, we conclude that this corresponds to approximately 1.240815451 metric tons of CFC-11 equivalent.

Among our emissions measured and calculated using the Brazilian GHG Protocol Program (PBGHG, in Portuguese) tool, in reference year 2022, we recorded emissions of N2O (nitrous oxide), which is one of the nitrogen oxides (NOx). In this reporting cycle, we accounted for a total of 153.04 metric tons of N2O, across scopes 1 and 3 (direct and indirect emissions, respectively). In our operations, a considerable amount of this gas is used as a general anesthetic, typically administered during surgical procedures in hospital units. No other significant emissions from the requested categories were calculated (SOx emissions, persistent organic pollutants (POPs), volatile organic compounds (VOCs), hazardous air pollutants (HAPs) and particulate matter (PM)).

Our climate and emissions-related goals can be reviewed in the “ESG Goals” chapter, under the material topics “Energy,” “Waste,” and “Climate Change.”

On June 4, 2023, in celebration of World Environment Day, the Company set up an initiative to enrich the Atlantic Forest by planting 30 native tree seedlings in the Sugarloaf and Urca Mountains Natural Monument. The initiative was carried out in partnership with the “Pão de Açúcar Verde” (Green Sugarloaf) project. Also to commemorate World Environment Day, the Company held fun training sessions at the Coração do Brasil and DF Start units. At the event, employees had the opportunity to understand the importance of maintaining a balanced environment. A webinar was also held, in the form of a round table discussion, covering many material topics. Employees and external experts were invited to participate.

Waste management

GRI 3-3, 306-1, 306-2

Our operations produce both hazardous (biological, sharps, and chemical) and non-hazardous (organic and inorganic) waste, which are correctly disposed of according to their nature. For non-hazardous waste, only those that are not technically or economically feasible to undergo recycling or other disposal methods are sent to landfills. Hazardous waste, on the other hand, is sent to specialized companies, with chemicals being sent for incineration and biological waste and sharps for autoclaving.

Disposable inputs are segregated at the source by the hygiene teams of the units, weighed, and packaged according to the guidelines of RDC 222/2018, issued by the National Health Surveillance Agency (Anvisa, in Portuguese), and collected and treated by third-party companies, according to applicable treatments, as mentioned. These companies undergo a homologation process, where technical and legal documents are evaluated, and their facilities and processes are audited before they are hired. To ensure ongoing compliance with all regulations, suppliers undergo regular spot audits following their contracting [GRI 2-25].

The waste generation profile of each unit is monitored through the Schneider Electric’s Resource Advisor system, which collects data on weighing, disposal, management costs, and waste traceability documents.

Waste generated by composition of waste (t) | GRI 306-3, SASB HC-DY-150a.1

Classification Composition

20237, 10

20226

20215

Group A1

RSS - Infectious 8,268.02 (21.9%) 8,985.32 (22.7%) 11,944.01 (29.5%)

Group B1

RSS – Chemicals 523.16 (1.4%) 962.87 (2.4%) 1,126.78 (2.8%)

Group D1

RSS – common waste (organic) 24,832.71 (65.8%) 25,610.25 (64.8%) 23,891.69 (59.1%)

Group E1

RSS – Sharps 527.36 (1.4%) 759.15 (1.9%) 768.36 (1.9%)
Hazardous recyclables

Lamps4

6.45 (~0.0%) 3.77(~0.0%) 2.80 (~0.0%)
Batteries 4.38 (~0.0%) 2.68 (~0.0%) 2.75 (~0.0%)

Electronic equipment8

100.29 (0.3%) 85.96 (0.2%) 134.77 (0.3%)
Non-hazardous recyclables Paper, metal, plastic, glass, and others 2,984.44 (7.9%) 2,637.63 (6.7%) 2,215.26 (5.5%)
Organic 478.08 (1.3%) 467.33 (1.2%) 337.12 (0.8%)
Total waste generated (t) 37,724.87 39,514.96 40,423.54

Waste generation rate (t/pt./day)9

0.0138 0.0143 0.0160

Comparison to previous report²

Decrease

Waste diverted from disposal | GRI 306-4, SASB HC-DY-150a.1

Classification Composition

Recovery (outside the organization)³

20237, 10

20226

20215

Hazardous waste

Lamps4

Recycling 6.45 (0.2%) 3.77 (0.1%) 2.80 (0.1%)
Batteries 4.38 (0.1%) 2.68 (0.1%) 2.75 (0.%)

Electronic equipment8

100.29 (2.8%) 85.96 (2.7%) 134.77 (5.0%)
Non-hazardous waste Food waste Composting 478.08 (13.4%) 467.33 (14.6%) 337.12 (12.5%)
Paper, metal, plastic, glass, and others Recycling 2,984.44 (83.5%) 2,637.63 (82.5%) 2,215.26 (82.3%)
Total waste diverted from disposal (t) 3,573.64 3,197.37 2,692.70

Intensity of waste diverted from disposal (t/pt.) 9

0.0013 0.0012 0.0011

Comparison to previous report²

Increased

Waste directed to disposal (t) | GRI 306-5, SASB HC-DY-150a.1

Classification Composition Final disposal method (outside the organization)³

20237, 10

20226

20215

Hazardous waste

RSS – Infectious4

Other disposal operations (autoclaving) 6,245.42 (18.3%) 5,571.15 (15.3%) 11,944.01 (31.7%)
Incineration (without energy recovery) 2,022.60 (5.9%) 3,414.17 (9.4%)
RSS - Chemicals Incineration (without energy recovery) 523.16 (1.5%) 962.87 (2.7%) 1,126.78 (3.0%)

RSS - Sharps4

Other disposal operations (autoclaving) 350.94 (1.0%) 347.88 (1.0%) 768.36 (2.0%)
Incineration (without energy recovery) 176.42 (0.5%) 411.27 (1.1%)
Non-hazardous waste RSS - Common waste (organic) Landfill containment 24,832.71 (72.7%) 25,610.25 (70.5%) 23,891.69 (63.3%)
Total waste directed to disposal (t) 34,151.25 36,317.59 37,730.84

Waste directed to final disposal (t/pt.)9

0.012 0.013 0.015

Comparison to previous report²

Decreased

1 Healthcare Waste (RSS, in Portuguese) classification into groups A, B, C, D, and E, according to ANVISA’s Collegiate Board Resolution (RDC) No. 222/2018. Group C (radioactive) is not counted.

2 Total waste generated by the Company decreased by about 3.6% (consolidated intensity). This can be attributed to the structuring of the Waste Management Program and its waste reduction subprogram, as well as the intensification of provided training.

3 With regard to “waste diverted from disposal” [GRI 306-4], there is no waste classified as “preparation for reuse” or “other recovery operations”. The other disposal methods include “waste directed to disposal” [GRI 306-5] and the Company does not have waste classified as “incineration (with energy recovery)”, while waste from “other disposal operations” is autoclaved. Waste reported in [GRI 306-4] and [GRI-306-5] is sent outside the organization, so there is no waste classified as “within the organization”. The sum of indicators GRI 306-4 and GRI 306-5 (consolidated) includes GRI 306-3 (consolidated waste generated). We have adjusted the reporting of these indicators in relation to the previous reporting cycle due to a more assertive interpretation of what is requested in their protocol [GRI 2-4].

4 The lamp indicator includes both fluorescent and LED lamps. . As of 2022, it was possible to account for infectious waste and sharps with the final disposal methods separated into “incineration (without energy recovery) and “other disposal operations (autoclaving)”, as reported in GRI 306-5.

5 2021 data includes Hospital São Lucas (RJ) information for August and September, only.

6 The values presented in 2022 for Maternidade Star were only considered from May onwards, when the unit began its operations.

7 The values presented in 2023 for the São Luiz Campinas unit were only considered from March onwards, when the unit began its operations.

8 In the previous reporting cycle, electronic devices was reported as ‘non-hazardous,’ while this year they are classified as ‘hazardous.’ Furthermore, there was a restatement in the volume for 2021 from 133.68 t to 134.77 t, and for 2022 from 92.41t to 85.96t. This change is negligible as it was less than 10% for each year, and given the proportion of this waste in relation to others [GRI 2-4].

9 As this is a metric whose denominator is specific to hospital-owned units, the intensity calculation only considers this type of business. In any case, the amount of waste generated by hospitals corresponds to practically 100% of the volume. Thus, the numerator considered the total waste generated (hazardous and non-hazardous) in hospitals was 13,067.98t (hazardous) and 24,767.56 t (non-hazardous), totaling 37,835.55 t for 2021; and 10,181.52t (hazardous) and 27,834.01t (non-hazardous), totaling 38,015.53t for 2022; and 9,295.31t (hazardous) and 28,160.865t (non-hazardous), totaling 37,456.18t for 2023.We recognize that the ideal is to have separate reporting by business type, and consolidated, and we will evaluate this possibility for the next cycles.

10 This year, these indicators include the hospital units (with the exception of the Badim, Cinco de Outubro and Yutaka Takeda units), the oncology units, the Richet units, two IDOR units and three corporate units.

Waste is also a strategic material topic in our ESG Strategic Planning. Each of our hospital units has its Healthcare Waste Management Plan (PGRSS, in Portuguese), approved by the relevant regulatory body. The initiative is overseen by the corporate Sustainability and Environment team, which is also responsible for the annual environmental audits, conducted internally to ensure the proper execution of all internal norms and procedures, as well as municipal, state, and federal regulations, and externally to ensure the proper provision of waste collection, transportation, treatment, disposal, and final disposal services. In 2023, investments in waste management amounted to BRL 31.9 million.

Internal audits follow an Environmental Risk Matrix, established to determine risk levels for each unit, considering many material criteria. Throughout 2023, 93 internal environmental audits and 23 external audits were conducted. In internal audits, 1,714 events were identified, and 733 actions were implemented. We recorded a 43% effectiveness rate in reducing recurring non-conformities [GRI 2-25].

We have implemented a waste management program consisting of three main subprograms structured around this topic, following the waste disposal hierarchy outlined in the National Solid Waste Policy (PNRS, in Portuguese, Federal Law 12305/2010):Waste Reduction; Reverse Logistics, Reuse, and Recycling; Use of Recycled Materials.

invested in waste management

In 2023, we had a

reduction in
the total quantity of hazardous waste generated

Reduction in

total
waste generated

We have forged several partnerships aimed at reducing the volume of waste generated, such as the partnership with the brand Lindoya Verão, prioritizing the acquisition of water bottles with reduced polyethylene terephthalate (PET) content.

Additionally, we have partnered with Janssen to transition deliveries of perishables and dry cargo to returnable packaging, eliminating the use of cardboard, Styrofoam, and plastic in our logistics operation, reducing waste traffic.

Many initiatives carried out in our units contribute to reducing waste generation and, in some cases, generating savings. This is the case with the replacement of disposable cups at the construction site of Novo Barra D’Or in Rio de Janeiro (RJ). The projection was to use 1.4 million cups over 14 months of construction, at an estimated cost of BRL 84,000. By switching to silicone cups and reusable bottles, only BRL 7.300 was spent, effectively mitigating a significant environmental impact.

Another example of this nature is the standardization process of disposable curtains. The model using plastic hooks was replaced by another fixed with adhesive tapes, resulting in a 17% reduction in the average price of curtains and the removal of approximately 800 kilograms of plastic from the environment every month (more information in Incentive for good practices).

Throughout 2023, we managed to reduce the rate of waste generated in our operations from 0.0143 to 0.0138 t/patient/day [GRI 306]. Of the total waste generated, 25% was classified as hazardous waste. We had a 13% reduction in the total quantity of such waste compared to the previous year, which is sent for special disposal methods such as burning mass incineration or autoclaving.

Of the total non-hazardous waste, 12% of group D was sent for recycling and composting, while the remaining volume went to sanitary landfills. No significant contaminations or leaks of any kind were recorded.

All our units encourage employees to recycle. Waste collected for this purpose is directed to specialized companies, which reprocess it in accordance with current environmental legislation or send it to recycling cooperatives.

Since 2022, we have had a monthly monitoring tool to track compliance with the recycling targets of our hospital units, the Reciclômetro, which helps us achieve our goal of reaching a 30% recyclable waste rate by 2030. For more information, see the target performance in the material topic “waste” in the “ESG Goals” chapter.

Some recycling and material reuse practices contribute to reducing the volume of waste sent to landfills. One such practice involves re-purposing SMS blankets, which are typically used to package sterilized medical-hospital products, to make eco-friendly bags, cellphone holders, car trash bins, aprons, among other items.

Although widely practiced in our hospital units, selective waste collection was not yet a reality in the corporate offices in Rio de Janeiro. Therefore, in 2023, a pilot project was initiated to test the initiative, with the provision of labeled bins for each type of recyclable material, education campaigns, awareness activities, and training sessions, along with the launch of our Selective Collection Guide, aimed at enhancing the practice in our healthcare units. As a result, Hospital Esperança Olinda (PE) implemented waste storage bins for selective collection and conducted various educational activities in the “Recycling Month” campaign.

Geared towards reusing recycled materials and incorporating them into hospital activities, some units have part of their uniforms made from mixed fabrics with recycled polyester fibers produced by a supplier that works with PET bottle recycling to produce recycled polyester.

The process of obtaining recycled PET fiber is as follows:

  • Used PET packaging is collected, sorted, and ground into flakes;
  • The flakes undergo an extrusion process and are transformed back into PET resin;
  • The recycled resin undergoes a high-tech process, turning into polyester fiber;
  • This polyester fiber, combined with cotton, results in high-performance fabrics with a pleasant touch and excellent comfort level.

Details on some of the most recent results can be seen in the chapter "Curtains made of mixed recycled polyester fabrics from PET bottles.".

Rede D’Or ©2024 - All rights reserved.
Privacy policies
powered by
blendON
magnifiercrossmenu